Abstract

O3–058 - A Phase II Study of Neoadjuvant Weekly Paclitaxel with and without Trastuzumab in Elderly Breast Cancer Patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P4-05-08: Genomic landscape of breast cancer occurring in elderly individuals
Pedram Razavi ... David N Brown
Cancer Research | VOL. 80
Pedram Razavi, et. al.Pedram Razavi ... David N Brown
14 Feb 2020
Abstract P1-11-21: Analysis of cognitive function in elderly HER2-positive breast cancer patients receiving either trastuzumab monotherapy or trastuzumab plus chemotherapy as a postoperative adjuvant treatment: A cognitive function sub-study of a randomized, open-label, phase 3 clinical trial (RESPECT trial)
K Kobayashi ... H Mukai
Cancer Research | VOL. 79
K Kobayashi, et. al.K Kobayashi ... H Mukai
15 Feb 2019
Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
Jiyang Lv ... Fangfang Wu
Cellular and molecular biology (Noisy-le-Grand, France) | VOL. 70
Jiyang Lv, et. al. Jiyang Lv ... Fangfang Wu
31 Mar 2024
Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals
J.-P Bergerat ... J.-E Kurtz
Critical Reviews in Oncology / Hematology | VOL. 79
J.-P Bergerat, et. al.J.-P Bergerat ... J.-E Kurtz
23 Jul 2010
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers